Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00830362 · ClinicalTrials.gov registry record · Phase 2
Beta-blockade Effects on Memory for Cocaine Craving
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00830362 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 50 participants.
The verdict
NCT00830362, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of propranolol versus placebo on responses to cocaine cues in cocaine dependent individuals.
Interventions
- DRUG Placebo
- DRUG Propranolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00830362
The ClinicalTrials.gov registry entry for NCT00830362 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00830362 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00830362 about?
NCT00830362 is a clinical study titled "Beta-blockade Effects on Memory for Cocaine Craving". The purpose of this study is to examine the effects of propranolol versus placebo on responses to cocaine cues in cocaine dependent individuals.
What is the current status of trial NCT00830362?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2009-02. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00830362?
The interventions under investigation include: Placebo (DRUG), Propranolol (DRUG).
Who is sponsoring clinical trial NCT00830362?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.